Showing 17,481 - 17,500 results of 101,525 for search '(( 5 ((ng decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (teer decrease)) ))', query time: 1.94s Refine Results
  1. 17481
  2. 17482
  3. 17483
  4. 17484
  5. 17485
  6. 17486
  7. 17487
  8. 17488
  9. 17489
  10. 17490
  11. 17491
  12. 17492

    Autophagic machinery is involved in cross-over endocytosis. by Nora Gehne (4357123)

    Published 2017
    “…<p><b>A</b>: Cocultures of mTurquoise2 (TRQ)-Cldn5 or LC3 labeled with red and green fluorescent protein (RFP-GFP-LC3) mono-transfected in Madin-Darby canine kidney cells II (MDCK-II). …”
  13. 17493

    A significant interaction of FC among cerebellar sub-regions and cerebral cortexes. by Mengling Shao (7450343)

    Published 2019
    “…The experimental group had stronger FC between left cerebellar hemispheric IV-V (A) and right cerebellar hemispheric VIII (B); between right cerebellar hemispheric VIII (B) and right hippocampus (C); between right cerebellar hemispheric VIII (B) and left middle cingulate gyrus (D); between cerebellar vermal IX (E) and right cerebellar hemispheric VIII (B) after training. …”
  14. 17494
  15. 17495

    V3-loop changes in Env<sub>HXB2</sub> do not alter the irreversibility of anti-MPER NAb 10E8v4 neutralization. by Hannah M. Schapiro (12563123)

    Published 2022
    “…HIV-1 was suspended in media with and without NAb 10E8v4 at 2-4x IC50 concentration to form the full-strength samples. …”
  16. 17496
  17. 17497
  18. 17498
  19. 17499
  20. 17500

    DataSheet1_A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center,... by Anju Majeed (19169428)

    Published 2024
    “…</p>Methods<p>Based on the inclusion/exclusion criteria, 105 newly diagnosed participants with degenerative hypertrophy OA were recruited and randomized into Placebo, BSE-150 mg or BSE-300 mg (n = 35 in each group) to receive either 150 mg or 300 mg BSE or a placebo tablet twice a day for 90 days. All the participants were evaluated for pain and physical function using the standard tools including the Visual Analog Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Lequesne Functional Index (LFI), EuroQol- 5 Dimension (EQ-5D) quality of life, 6-min walk test at day 0, days 5, 30, 60 and 90 of treatment. …”